MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-WB-10-0027689
Xenex Pharmaceuticals Private Limited
Xenex Pharmaceuticals Private Limited - pharma in Kolkata, West Bengal, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹55.07 Lakh
▲ 6048% YoY
Net loss · FY 2024
₹2.04 Lakh
Net margin -3.7%
EBITDA · FY 2024
-₹2.04 Lakh
EBITDA margin -3.7%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Open charges
₹99 Lakh
Secured borrowings
Company age
7 yrs
Est. 2019
Directors on board
5
As per MCA filings
About Xenex Pharmaceuticals Private Limited
Data last updated:
Xenex Pharmaceuticals Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 20 February 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24290WB2019PTC230567.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Vatsal Arya and Pravisha Arya.
Its last annual general meeting (AGM) was held on 25 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Kolkata, West Bengal.
As per the financials filed for FY 2024, the company reported a revenue of ₹55.07 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹2.04 Lakh (net margin -3.7%) and EBITDA of -₹2.04 Lakh (EBITDA margin -3.7%). Revenue has grown at a compounded annual rate (CAGR) of 328% over three years.
As per MCA filings, the company has open charges of ₹99 Lakh on record. The company has 2 deals on record (2 secondary share transfers); the latest was in June 2021.
Xenex Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-WB-10-0027689). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24290WB2019PTC230567
Registration Number 230567
Incorporation Date 20 February 2019
ROC Kolkata
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-WB-10-0027689
Recognitions & Rankings of Xenex Pharmaceuticals
Contact details
Xenex Pharmaceuticals Private Limited's registered office is in Kolkata, West Bengal. Its e-mail address is in the company report.
- Email
- Registered Address43, Kailash Bose Street, Kolkata, West Bengal, India – 700006
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Xenex Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Xenex Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Xenex Pharmaceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Xenex Pharmaceuticals Private Limited, buy the company report.
Financials of Xenex Pharmaceuticals Private Limited
FY 2025 filings availableXenex Pharmaceuticals Private Limited reported revenue of ₹55.07 Lakh (up 6048% YoY) for FY 2024.
Revenue · FY 2024
₹55.07 Lakh ▲ 6048%
Net loss · FY 2024
₹2.04 Lakh margin -3.7%
EBITDA · FY 2024
-₹2.04 Lakh margin -3.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
3 years · compounded
▲ 328%
EBITDA CAGR growth
1 year
▼ 545%
3 years · compounded
▼ 74%
Revenue has grown at a compounded annual rate (CAGR) of 328% over three years. EBITDA fell 545% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹2.04 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2.04 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -3.7% | ||||
| Net Profit Margin | -3.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Xenex Pharmaceuticals Private Limited, buy the company report.
Board of directors of Xenex Pharmaceuticals Private Limited
Xenex Pharmaceuticals has 5 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vatsal Arya | Director | 10 Jul 2021 | 5 Years 4 Months | Current |
| Pravisha Arya | Director | 06 May 2024 | 2 Years 6 Months | Current |
| Alok Arya Also directs: Eastern Photo Services Private Limited, Swabhiman Engineering Private Limited, Xenex Hotels & Resorts Private Limited and 1 more | Director | 05 Dec 2019 | 6 Years 11 Months | Current |
| Amit Arya | Director | 20 Feb 2019 | 7 Years 8 Months | Current |
| Ashok Arya Also directs: Eastern Photo Services Private Limited | Director | 10 Jul 2021 | 5 Years 4 Months | Current |
Auditor
Xenex Pharmaceuticals Private Limited is audited by R D A & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R D A & ASSOCIATES | FY 2020 | 322810E |
Charges & borrowings
Open charges
₹99 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 21 Aug 2025 | 101142833 | Hdfc Bank Limited | ₹99 Lakh | Open |
Total charge records: 1 View all charges
Deals & funding
Xenex Pharmaceuticals Private Limited has 2 deals on record (2 secondary share transfers); the latest was in June 2021.
Total deals
2
Secondary share transfers
2
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jun 2021 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2021 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Xenex Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Xenex Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Xenex Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Xenex Pharmaceuticals Private Limited has 9 board changes on record since 2019: 5 appointments and 4 cessations. The latest: Pravisha Arya ceased to be Additional Director on 29 Sep 2024.
AGM
Xenex Pharmaceuticals Private Limited last Annual general meeting of members was held on 25 Sep 2025 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 99.00 Lakh with Charge ID 101142833 was registered on 21 Aug 2025.
Filing
Xenex Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata I.
Ceased
Pravisha Arya ceased to be Additional Director.
Appointed
Pravisha Arya was appointed as Director.
Ceased
Ashok Arya ceased to be Additional Director.
Ceased
Vatsal Arya ceased to be Additional Director.
Appointed
Ashok Arya was appointed as Director.
Appointed
Vatsal Arya was appointed as Director.
Ceased
Subhasish Bhattacharjee ceased to be Director.
Appointed
Alok Arya was appointed as Director.
Appointed
Amit Arya was appointed as Director.
1 earlier event is in the company report.
Frequently asked questions
Xenex Pharmaceuticals is an active private limited company based in Kolkata, West Bengal, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 20 February 2019 (7+ years old) and is registered under CIN U24290WB2019PTC230567.
Xenex Pharmaceuticals has 5 current directors:
- Vatsal Arya - Director
- Pravisha Arya - Director
- Alok Arya - Director
- Amit Arya - Director
- Ashok Arya - Director
The latest financial statements of Xenex Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 25 September 2025. Year-wise statements from FY 2019 are in the company report.
The CIN (Corporate Identification Number) of Xenex Pharmaceuticals is U24290WB2019PTC230567. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Xenex Pharmaceuticals was incorporated on 20 February 2019, making it 7+ years old. It is registered with the Registrar of Companies, Kolkata.
Xenex Pharmaceuticals has 2 deals on record (2 secondary share transfers); the latest was in June 2021.
Pravisha Arya ceased to be Additional Director on 29 Sep 2024. Pravisha Arya was appointed as Director on 06 May 2024. Ashok Arya ceased to be Additional Director on 30 Nov 2021. Xenex Pharmaceuticals has 9 board changes on record in total.
Yes, Xenex Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-WB-10-0027689).
The registered office of Xenex Pharmaceuticals is at 43, Kailash Bose Street, Kolkata, West Bengal, India – 700006.
Xenex Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages